According to Nevro
's latest financial reports the company has a price-to-book ratio of 1.42.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.66 | -38.65% |
2022-12-31 | 4.33 | -53.52% |
2021-12-31 | 9.32 | -39.25% |
2020-12-31 | 15.3 | -10.48% |
2019-12-31 | 17.1 | 257.45% |
2018-12-31 | 4.79 | -41.6% |
2017-12-31 | 8.21 | -2.19% |
2016-12-31 | 8.39 | 3.63% |
2015-12-31 | 8.10 | 44.93% |
2014-12-31 | 5.59 | |
2013-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 4.67 | 230.28% | ๐บ๐ธ USA |
Abiomed ABMD | 11.2 | 688.41% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | 9.94 | 602.10% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | 0.8122 | -42.61% | ๐บ๐ธ USA |